OpenAI Governance Trial AI Sector and Investment Implications What JV transaction Odysightai ODYS Odysightai posts 1042 negative EPS surprise REVB Revelation Biosciences reports vastly wider Q4 2025 loss than estimates shares end flat for the trading day